152 related articles for article (PubMed ID: 19245874)
1. Epigenetics in hyperhomocysteinemic states. A special focus on uremia.
Ingrosso D; Perna AF
Biochim Biophys Acta; 2009 Sep; 1790(9):892-9. PubMed ID: 19245874
[TBL] [Abstract][Full Text] [Related]
2. Hyperhomocysteinemia in uremia--a red flag in a disrupted circuit.
Perna AF; Ingrosso D; Violetti E; Luciano MG; Sepe I; Lanza D; Capasso R; Ascione E; Raiola I; Lombardi C; Stenvinkel P; Massy Z; De Santo NG
Semin Dial; 2009; 22(4):351-6. PubMed ID: 19708980
[TBL] [Abstract][Full Text] [Related]
3. Folic acid effects on s-adenosylmethionine, s-adenosylhomocysteine, and DNA methylation in patients with intermediate hyperhomocysteinemia.
Pizzolo F; Blom HJ; Choi SW; Girelli D; Guarini P; Martinelli N; Stanzial AM; Corrocher R; Olivieri O; Friso S
J Am Coll Nutr; 2011 Feb; 30(1):11-8. PubMed ID: 21697534
[TBL] [Abstract][Full Text] [Related]
4. Folate treatment and unbalanced methylation and changes of allelic expression induced by hyperhomocysteinaemia in patients with uraemia.
Ingrosso D; Cimmino A; Perna AF; Masella L; De Santo NG; De Bonis ML; Vacca M; D'Esposito M; D'Urso M; Galletti P; Zappia V
Lancet; 2003 May; 361(9370):1693-9. PubMed ID: 12767735
[TBL] [Abstract][Full Text] [Related]
5. Plasma proteins containing damaged L-isoaspartyl residues are increased in uremia: implications for mechanism.
Perna AF; Castaldo P; De Santo NG; di Carlo E; Cimmino A; Galletti P; Zappia V; Ingrosso D
Kidney Int; 2001 Jun; 59(6):2299-308. PubMed ID: 11380834
[TBL] [Abstract][Full Text] [Related]
6. Hyperhomocysteinemia-mediated DNA hypomethylation and its potential epigenetic role in rats.
Jiang Y; Sun T; Xiong J; Cao J; Li G; Wang S
Acta Biochim Biophys Sin (Shanghai); 2007 Sep; 39(9):657-67. PubMed ID: 17805460
[TBL] [Abstract][Full Text] [Related]
7. Metabolic consequences of hyperhomocysteinemia in uremia.
Perna AF; Ingrosso D; Satta E; Romano M; Cimmino A; Galletti P; Zappia V; De Santo NG
Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S85-90. PubMed ID: 11576929
[TBL] [Abstract][Full Text] [Related]
8. Homocysteine-lowering vitamins do not lower plasma S-adenosylhomocysteine in older people with elevated homocysteine concentrations.
Green TJ; Skeaff CM; McMahon JA; Venn BJ; Williams SM; Devlin AM; Innis SM
Br J Nutr; 2010 Jun; 103(11):1629-34. PubMed ID: 20089204
[TBL] [Abstract][Full Text] [Related]
9. Role of S-adenosylhomocysteine in cardiovascular disease and its potential epigenetic mechanism.
Xiao Y; Su X; Huang W; Zhang J; Peng C; Huang H; Wu X; Huang H; Xia M; Ling W
Int J Biochem Cell Biol; 2015 Oct; 67():158-66. PubMed ID: 26117455
[TBL] [Abstract][Full Text] [Related]
10. Intracellular S-adenosylhomocysteine increased levels are associated with DNA hypomethylation in HUVEC.
Castro R; Rivera I; Martins C; Struys EA; Jansen EE; Clode N; Graça LM; Blom HJ; Jakobs C; de Almeida IT
J Mol Med (Berl); 2005 Oct; 83(10):831-6. PubMed ID: 15976919
[TBL] [Abstract][Full Text] [Related]
11. Tissue levels of S-adenosylhomocysteine in the rat kidney: effects of ischemia and homocysteine.
Kloor D; Delabar U; Mühlbauer B; Luippold G; Osswald H
Biochem Pharmacol; 2002 Feb; 63(4):809-15. PubMed ID: 11992651
[TBL] [Abstract][Full Text] [Related]
12. [Hyperhomocysteinemia in chronic renal failure.].
Satta E; Perna AF; Lombardi C; Acanfora F; Violetti E; Romano MM; Capasso R; Pisano M; Paduano F; De Santo NG
G Ital Nefrol; 2006; 23(5):480-9. PubMed ID: 17123261
[TBL] [Abstract][Full Text] [Related]
13. Vitamin B Supplementation and Nutritional Intake of Methyl Donors in Patients with Chronic Kidney Disease: A Critical Review of the Impact on Epigenetic Machinery.
Cappuccilli M; Bergamini C; Giacomelli FA; Cianciolo G; Donati G; Conte D; Natali T; La Manna G; Capelli I
Nutrients; 2020 Apr; 12(5):. PubMed ID: 32349312
[TBL] [Abstract][Full Text] [Related]
14. Increased homocysteine and S-adenosylhomocysteine concentrations and DNA hypomethylation in vascular disease.
Castro R; Rivera I; Struys EA; Jansen EE; Ravasco P; Camilo ME; Blom HJ; Jakobs C; Tavares de Almeida I
Clin Chem; 2003 Aug; 49(8):1292-6. PubMed ID: 12881445
[TBL] [Abstract][Full Text] [Related]
15. The comprehensive effects of hyperlipidemia and hyperhomocysteinemia on pathogenesis of atherosclerosis and DNA hypomethylation in ApoE-/- mice.
Jiang Y; Zhang H; Sun T; Wang J; Sun W; Gong H; Yang B; Shi Y; Wei J
Acta Biochim Biophys Sin (Shanghai); 2012 Oct; 44(10):866-75. PubMed ID: 23017835
[TBL] [Abstract][Full Text] [Related]
16. Combined modulation of S-adenosylmethionine biosynthesis and S-adenosylhomocysteine metabolism enhances inhibition of nucleic acid methylation and L1210 cell growth.
Kramer DL; Porter CW; Borchardt RT; Sufrin JR
Cancer Res; 1990 Jul; 50(13):3838-42. PubMed ID: 2354436
[TBL] [Abstract][Full Text] [Related]
17. Metabolic consequences of folate-induced reduction of hyperhomocysteinemia in uremia.
Perna AF; Ingrosso D; De Santo NG; Galletti P; Brunone M; Zappia V
J Am Soc Nephrol; 1997 Dec; 8(12):1899-905. PubMed ID: 9402092
[TBL] [Abstract][Full Text] [Related]
18. Plasma choline and betaine correlate with serum folate, plasma S-adenosyl-methionine and S-adenosyl-homocysteine in healthy volunteers.
Imbard A; Smulders YM; Barto R; Smith DE; Kok RM; Jakobs C; Blom HJ
Clin Chem Lab Med; 2013 Mar; 51(3):683-92. PubMed ID: 23095202
[TBL] [Abstract][Full Text] [Related]
19. Hyperhomocysteinemia and macromolecule modifications in uremic patients.
Perna AF; Capasso R; Lombardi C; Acanfora F; Satta E; Ingrosso D
Clin Chem Lab Med; 2005; 43(10):1032-8. PubMed ID: 16197294
[TBL] [Abstract][Full Text] [Related]
20. Alterations in S-adenosylhomocysteine metabolism decrease O6-methylguanine DNA methyltransferase gene expression without affecting promoter methylation.
Hermes M; Geisler H; Osswald H; Riehle R; Kloor D
Biochem Pharmacol; 2008 Jun; 75(11):2100-11. PubMed ID: 18395186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
